Found: 5
Select item for more details and to access through your institution.
1271-PUB: Real-World Effectiveness of Newly Initiated Once-Weekly Semaglutide (sema OW) by Prescriber Specialty.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-1271-PUB
- By:
- Publication type:
- Article
683-P: Real-World Evaluation of Once-Weekly Semaglutide (Sema OW) in Patients Newly Initiating GLP-1 Agonist Therapy.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-683-P
- By:
- Publication type:
- Article
652-P: Real-World Effectiveness of Once-Weekly Semaglutide (sema OW) from a U.S. Commercially Insured and Medicare Advantage Population.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-652-P
- By:
- Publication type:
- Article
653-P: Evaluating Antidiabetic Medication Treatment Patterns in T2D Patients Initiating Once-Weekly Semaglutide (sema OW).
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-653-P
- By:
- Publication type:
- Article
953-P: Real-World Effectiveness of Once-Weekly Semaglutide (Sema OW) from a U.S. Commercially Insured and Medicare Advantage Population.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-953-P
- By:
- Publication type:
- Article